相关实验视频
为炎症性肠道疾病服用西奥普林的患者的淋巴增殖障碍:一项前性观察队列研究
Laurent Beaugerie1, Nicole Brousse, Anne Marie Bouvier
1Department of Gastroenterology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Université Pierre et Marie Curie Paris-VI, Paris, France. laurent.beaugerie@sat.aphp.fr
Lancet (London, England)
|October 20, 2009
概括
在提奥普林治疗中患有炎症性肠病的患者面临患有淋巴增殖性疾病的风险明显更高. 与从未使用过这些免疫抑制药物的人相比,这种风险显著增加.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 有争议的是,在使用西奥普林的炎症性肠病 (IBD) 患者中,淋巴扩散性疾病的风险增加.
- 为了评估这种风险,进行了一项前性观察队列研究.
研究的目的:
- 为了评估患有炎症性肠道疾病 (IBD) 的患者暴露在氨酸治疗中的淋巴扩散性疾病的风险.
- 为了比较接收,停止或从未使用硫氨酸的患者之间的这些疾病的发病率.
主要方法:
- 一个全国性的法国队列包括19486名IBD患者,由680名胃肠科医生收集的数据.
- 随访时间平均为35个月,记录了免疫抑制疗法,癌症和死亡.
- 淋巴增殖性疾病的风险是基于蒂奥普林暴露状态来分析的.
主要成果:
- 诊断出23例新的淋巴增殖性疾病 (1例霍奇金,22例非霍奇金).
- 每1000个患者年发生率为0.90 (接受提奥普林),0.20 (停止服用) 和0.26 (从未服用).
- 多变量分析显示,在提奥普林接受者与非接受者之间,淋巴增殖障碍的危险比为5.28 (p=0.0007).
结论:
- 治疗炎症性肠道疾病的提奥普林的患者患有淋巴增殖性疾病的风险增加.
- 许多与氨酸相关病例的病理概况类似于移植后的淋巴增殖性疾病.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...